Frequently Asked Questions:
The coronavirus pandemic has also impeded the development, manufacture, and distribution of medications and other healthcare products, as well as the growth of the healthcare sectors of many businesses globally.
North America held the largest market share for Bacterial Pneumonia.
Antibiotics are becoming less effective at treating bacterial pneumonia due to the rise in bacterial resistance. Pharmaceutical industry innovation is constantly focused on developing new kinds of antibiotics. These are the driving factor for this market.
Community-acquired Pneumonia segment had a major share in 2021.
Antibodies segment had a major share in the global market in 2021.